Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord blood-derived mesenchymal stem cell exosomes
- Development stage
- Unknown
- Lead developer
- General Authority for Teaching Hospitals and Institutes
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
This experimental cell-free biologic therapy consists of microvesicles (exosomes) derived from umbilical cord blood mesenchymal stem cells (UCB-MSCs). Developed by the General Committee of Teaching Hospitals and Institutes in Egypt, specifically at Sahel Teaching Hospital, it is currently being evaluated in a Phase 1 clinical trial (NCT02138331) for the treatment of type 1 diabetes mellitus. The therapy is designed to reduce the autoimmune-mediated inflammatory state that destroys pancreatic islet beta cells. By delivering these immunomodulatory vesicles via intravenous infusion, the treatment aims to improve beta-cell mass and function, thereby enhancing glycemic control in patients. It represents a novel approach in regenerative medicine, moving away from whole-cell stem cell transplantation to a cell-free extracellular vesicle modality.
- Other names
- MSC exosomesMSC microvesiclescell-free cord blood derived microvesiclesUCB-MSC-MVs
Beyond the preview
Go deeper on umbilical cord blood-derived mesenchymal stem cell exosomes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord blood-derived mesenchymal stem cell exosomes.